Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Agribusiness and Applied Economics at North Dakota State University.
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions


After a sluggish and error-prone beginning to a country-wide effort to vaccinate Americans against Covid-19, it seems things are quickly improving.  According to the Centers for Disease Control, as of March 18th, nearly 113 million Americans have received at least Covid-19 vaccination (two of the three available vaccines require two separate injections). The agency...
Read More »

Are We Witnessing the Beginning of the Covid-19 Ratchet Effect?


Nearly 13 months after the first confirmed Covid-19 infection in the US, President Biden held a memorial as the country surpassed 500,000 deaths attributed to the pandemic. Mourning a great tragedy, President Biden noted these casualties surpass the lives lost during WWI, WWII, and the Vietnam War combined. While alarmingly high fatalities signify a...
Read More »

The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug


In March 2019, an experimental drug designed to treat Alzheimer’s disease named aducanumab failed a futility test during the process for approval from the Food and Drug Administration. Facing seemingly little hope for success, aducanumab’s producers Biogen and Eisai strongly considered abandoning the project. However, when the drugmakers conducted further analysis on a larger...
Read More »

President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He Succeed?


President Biden seems comfortable using the executive branch’s power to push his agenda. As of February 2, 2021 (less than two weeks after taking office), he has signed 25 executive orders on issues ranging from environmental policy, racial equality, Covid-19 relief, and reinstating elements of the Affordable Care Act. While passing an unprecedented amount...
Read More »

Capping Insulin Copays Won’t Cure Insulin Price Woes


In 1996, a vial of Humalog (roughly a month’s supply) cost patients about $25 per vial. By 2017, the anti-diabetes medication cost nearly $275. Insulin prices have only increased since then. A Business Insider article estimates that from 2017 to 2019 the average diabetic spent $300 to $400 for a month’s supply of insulin....
Read More »

Early Covid-19 Vaccine Distribution Troubles Add to a Long List of Government Pandemic Failures


It’s been nearly twelve months since Covid-19 reached the United States. Since then, more than 19 million U.S. citizens have contracted the disease, resulting in just over 334,000 deaths. Well-intended but often misguided policy responses have added high unemployment, financial strife, and widespread mental health concerns to an already deeply troubling situation.

New COVID-19 Vaccines, Same Sluggish FDA


In October, large portions of the United States began experiencing rapid increases in new COVID-19 cases. Many European countries have experienced a similar surge in cases, even after being devastated by severe COVID-19 outbreaks earlier this year. Fearing the arrival of a second wave, several states reenacted various lockdown measures to curb spreading disease....
Read More »

Public Health Bureaucracies Consolidate Power as Pandemic Continues


In a surprising memo released last month by Secretary of Health and Human Services Alex Azar, federal agencies under the umbrella of his department are now prohibited from passing additional regulations on food, medicines, medical devices, and vaccines without Azar’s approval. As stated in the memo, “Any prior delegation of rulemaking authority, including the...
Read More »

Economic Miscalculation and the Covid-19 Pandemic


As Covid-19 began to spread through the United States in February, many feared hospitals would become overwhelmed with infected patients. To meet the demands a global pandemic places on our healthcare system, the U.S. Army Corps of Engineers began hiring private contractors to build field hospitals to treat patients when hospitals hit capacity. The...
Read More »

FDA Approves Blood Plasma as Covid-19 Treatment


In the nearly eight months since Covid-19 arrived in the United States, the country has undergone extensive lockdowns, trying economic hardship, and prolonged social isolation. Despite these sacrifices to battle the pandemic, the U.S. continues to lead the world in total confirmed Covid-19 cases and Covid-19 fatalities. As of September 9, the Coronavirus Resource...
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org